Loading clinical trials...
Loading clinical trials...
A Multicentric Phase 2 Study of Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-MUTATED Acute Myeloid Leukemia
Conditions
Interventions
Venetoclax+azacitidine
Locations
1
Italy
EMATOLOGIA- AOU Policlinico S.Orsola
Bologna, Italy
Start Date
March 1, 2022
Primary Completion Date
January 1, 2025
Completion Date
January 1, 2025
Last Updated
March 16, 2022
NCT05564390
NCT03050268
NCT07320235
NCT06439199
NCT06782542
NCT05886049
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions